NCT05041517 is a NA clinical trial of BOLT + PTC in Mental Health Issue, sponsored by University of Washington.

Who is sponsoring NCT05041517?

NCT05041517 is sponsored by University of Washington.

What drugs are being tested in NCT05041517?

Interventions in NCT05041517: BOLT + PTC.

What condition does NCT05041517 study?

NCT05041517 studies Mental Health Issue, Adoption of Measurement-Based Care (MBC).

Is NCT05041517 still recruiting?

NCT05041517 is currently completed. Last updated 13 September 2021.

Last reviewed 2021-09-13 · How we verify

NCT05041517

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Brief Online Training (BOLT) for Routine Outcome Monitoring

Completed NA Last updated 13 September 2021

What this trial tests

NA trial testing BOLT + PTC in Mental Health Issue in 75 participants. Completed in 31 December 2020.

Timeline

16 February 2017

Primary endpoint
16 July 2019

31 December 2020

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	75
Start date	16 February 2017
Primary completion	16 July 2019
Estimated completion	31 December 2020
Sites	1 location across United States

Drugs / interventions tested

BOLT + PTC

Conditions studied

Mental Health Issue — all drugs for Mental Health Issue →
Adoption of Measurement-Based Care (MBC) — all drugs for Adoption of Measurement-Based Care (MBC) →

Sponsor

University of Washington

Who can join

Adults 22 to 80, any sex, with Mental Health Issue or Adoption of Measurement-Based Care (MBC). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this project is to improve school-based services by developing and testing an online training and consultation system to facilitate the use of measurement-based care (also known and referenced in original grant as routine outcome monitoring). Measurement-based care (MBC) is the target intervention because it is an EBP with extensive empirical support for its ability to improve mental health service outcomes and is a feasible and cost-effective option. Following the iterative development of the BOLT training and consultation package (phases 1-4), the investigators will conduct a randomized control pilot trial (phase 5) to test the (1) impact of the package on MBC knowledge, attitudes and use, (2) impact of varying degrees of consultation dosage on weekly assessments of MBC use, and (3) moderators and mechanisms of impact.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

How low can you go? Examining the effects of brief online training and post-training consultation dose on implementation mechanisms and outcomes for measurement-based care.
Lyon AR, Liu FF, Connors EH, King KM, et al · · 2022 · cited 18× · PMID 35869500 · DOI 10.1186/s43058-022-00325-y

Verify or expand the search:

Other recruiting trials for Mental Health Issue

Currently open trials in the same condition.

NCT07129070 — Just-in-Time Training for Youth Mentors · NA · recruiting
NCT07075081 — Gii'Igoshimong: Sitting With Your First Family · Phase 2 · recruiting
NCT07160439 — Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors · NA · recruiting
NCT06385457 — The Effects of Mindhelper.dk: a Self-guided Digital Mental Health Promotion Service Targeting Young People · NA · recruiting
NCT06442774 — MamaConecta: Digital Tool for Maternal Mental Health · NA · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05041517 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 13 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05041517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing